187 related articles for article (PubMed ID: 36827975)
1. SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants.
Hysenaj L; Little S; Kulhanek K; Magnen M; Bahl K; Gbenedio OM; Prinz M; Rodriguez L; Andersen C; Rao AA; Shen A; Lone JC; Lupin-Jimenez LC; Bonser LR; Serwas NK; Mick E; Khalid MM; Taha TY; Kumar R; Li JZ; Ding VW; Matsumoto S; Maishan M; Sreekumar B; Simoneau C; Nazarenko I; Tomlinson MG; Khan K; von Gottberg A; Sigal A; Looney MR; Fragiadakis GK; Jablons DM; Langelier CR; Matthay M; Krummel M; Erle DJ; Combes AJ; Sil A; Ott M; Kratz JR; Roose JP
Stem Cell Reports; 2023 Mar; 18(3):636-653. PubMed ID: 36827975
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator.
Hysenaj L; Little S; Kulhanek K; Gbenedio OM; Rodriguez L; Shen A; Lone JC; Lupin-Jimenez LC; Bonser LR; Serwas NK; Bahl K; Mick E; Li JZ; Ding VW; Matsumoto S; Maishan M; Simoneau C; Fragiadakis G; Jablons DM; Langelier CR; Matthay M; Ott M; Krummel M; Combes AJ; Sil A; Erle DJ; Kratz JR; Roose JP
bioRxiv; 2021 Jun; ():. PubMed ID: 34100012
[TBL] [Abstract][Full Text] [Related]
3. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
[TBL] [Abstract][Full Text] [Related]
4. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
[TBL] [Abstract][Full Text] [Related]
6. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
7. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating.
Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR
mBio; 2024 Apr; 15(4):e0312923. PubMed ID: 38477472
[TBL] [Abstract][Full Text] [Related]
8. Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids.
Flagg M; Goldin K; Pérez-Pérez L; Singh M; Williamson BN; Pruett N; Hoang CD; de Wit E
Emerg Microbes Infect; 2023 Dec; 12(2):2276338. PubMed ID: 37883246
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids
Kim MJ; Kim S; Kim H; Gil D; Han HJ; Thimmulappa RK; Choi JH; Kim JH
Emerg Microbes Infect; 2023 Dec; 12(1):2211685. PubMed ID: 37161660
[TBL] [Abstract][Full Text] [Related]
10. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.
O'Shea KM; Schuler CF; Chen J; Troost JP; Wong PT; Chen K; O'Shea DR; Peng W; Gherasim C; Manthei DM; Valdez R; Baldwin JL; Baker JR
Front Immunol; 2023; 14():1055429. PubMed ID: 36845123
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
[TBL] [Abstract][Full Text] [Related]
12. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
13. Apical-Out Human Airway Organoids Modeling SARS-CoV-2 Infection.
Chiu MC; Zhang S; Li C; Liu X; Yu Y; Huang J; Wan Z; Zhu X; Zhou J
Viruses; 2023 May; 15(5):. PubMed ID: 37243252
[TBL] [Abstract][Full Text] [Related]
14. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
Gandikota C; Vaddadi K; Sivasami P; Huang C; Liang Y; Pushparaj S; Deng X; Channappanava R; Metcalf JP; Liu L
J Med Virol; 2024 Apr; 96(4):e29579. PubMed ID: 38572923
[TBL] [Abstract][Full Text] [Related]
15. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
[TBL] [Abstract][Full Text] [Related]
16. The Human Nose Organoid Respiratory Virus Model: an
Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
[TBL] [Abstract][Full Text] [Related]
17. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
[TBL] [Abstract][Full Text] [Related]
18. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
[TBL] [Abstract][Full Text] [Related]
19. Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern.
McNamara RP; Maron JS; Boucau J; Roy V; Webb NE; Bertera HL; Barczak AK; Positives Study Staff T; Franko N; Logue JK; Kemp M; Li JZ; Zhou L; Hsieh CL; McLellan JS; Siedner MJ; Seaman MS; Lemieux JE; Chu HY; Alter G
mBio; 2023 Aug; 14(4):e0090223. PubMed ID: 37535402
[TBL] [Abstract][Full Text] [Related]
20. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
Li C; Huang J; Yu Y; Wan Z; Chiu MC; Liu X; Zhang S; Cai JP; Chu H; Li G; Chan JF; To KK; Yang Z; Jiang S; Yuen KY; Clevers H; Zhou J
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300376120. PubMed ID: 37068258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
